Case-by-case analysis
We offer a case-by-case, in-depth scientific analysis of genetic test results presenting complex and inconclusive findings (e.g., Variants of Uncertain Significance).
We provide independent, high-level scientific review of genetic test results in rare diseases, including Variants of Uncertain Significance (VUS)
Genetic testing is often performed to better understand a medical condition, particularly in rare diseases. In many cases, results clarify the origin and evolution of a condition and may support therapeutic decisions.
However, even when appropriately indicated and technically well performed, reports may identify findings such as a Variant of Uncertain Significance (VUS) that do not clearly explain the clinical situation.
Further high-level scientific reassessment can, in selected cases, provide additional clarity.
This is the purpose of our service: to provide a rigorous and independent scientific review that may contribute to the clinical interpretation of the reported genetic findings.
An independent, case-by-case scientific analysis of complex genetic findings.
We offer a case-by-case, in-depth scientific analysis of genetic test results presenting complex and inconclusive findings (e.g., Variants of Uncertain Significance).
Each case is analyzed independently from multiple perspectives to establish a rigorous technical and scientific opinion. An online live session with a specialist to address questions or concerns is also available.
A deliberate scientific sequence. Not an algorithmic black box.
The process unfolds in two clear stages, each with its own fee — so you only commit to the full review after the first screening confirms it is worthwhile.
You securely upload the relevant clinical information and genetic test report.
Our team will conduct an initial assessment to determine whether a comprehensive scientific evaluation can be performed.
Each case undergoes detailed scientific re-analysis supported by advanced computational tools. Our approach integrates population and molecular genetics, functional genomics data, evolutionary conservation, probability models, clinical information, and structured literature analysis.
The results can be downloaded confidentially, and an optional 20-minute conversation with a specialist will be available to address any questions or concerns.
Three inputs are enough to begin the review.
Patient identifiers should be removed whenever possible.
Describing onset, evolution, and current status.
If available.
Transparent, flat pricing in U.S. dollars.
The complete scientific reassessment.
A live conversation with our scientific team.
Two clear outputs — written and, if you choose, spoken.
Structured written scientific report detailing technical aspects, variant analysis, and independent interpretation.
Optional private discussion with the Scientific Director.

Scientific Director
All reviews are conducted by a molecular geneticist with extensive experience in rare diseases.
Each case is reviewed and validated by Professor Paul Laissue, Scientific Director of PLH Genetics, with over 25 years of experience in molecular genetics, functional genomics, and quantitative genetics research.
Short answers to what families and physicians ask most.
A VUS is a genetic change for which current evidence is insufficient to classify it as benign or disease-causing. A structured scientific reassessment can sometimes resolve that uncertainty.
Read the full VUS guide